SGN by compound
SGN records split by compound, with the index-wide comparison for the same compound beside each one. 21 compounds, 221 records. Cells below n=3 print their raw values instead of a median.
| Compound | Class | Reports | SGN median % | Index median % | Δ (pp) | Spec | Pass % |
|---|---|---|---|---|---|---|---|
| Tirzepatide | Incretin | 60 | 98.19 | 98.55 | -0.36 | 97.0 | 98 |
| Semaglutide | Incretin | 18 | 98.39 | 98.89 | -0.50 | 97.0 | 100 |
| TB-500 | Tissue-repair | 17 | 99.16 | 99.53 | -0.37 | 98.5 | 94 |
| GHRP-6 | Growth-hormone | 16 | 99.17 | 99.54 | -0.37 | 99.0 | 63 |
| N-Acetyl Semax Amide | Neuroactive | 13 | 98.61 | 99.35 | -0.74 | 98.5 | 62 |
| ARA-290 | Tissue-repair | 12 | 98.31 | 99.42 | -1.11 | 98.0 | 92 |
| GHK-Cu | Tissue-repair | 12 | 98.22 | 98.56 | -0.34 | 97.0 | 100 |
| Afamelanotide | Melanocortin-receptor | 11 | 98.42 | 99.06 | -0.64 | 98.0 | 100 |
| Triptorelin | Hypothalamic | 10 | 98.80 | 99.41 | -0.60 | 98.5 | 80 |
| BPC-157 | Tissue-repair | 9 | 98.59 | 99.16 | -0.57 | 98.0 | 100 |
| Sermorelin | Growth-hormone | 7 n=7 | 99.16 | 99.06 | +0.10 | 98.0 | 100 |
| Selank | Neuroactive | 7 n=7 | 98.28 | 99.59 | -1.31 | 99.0 | 0 |
| SLU-PP-332 | Non-peptide | 6 n=6 | 98.42 | 98.88 | -0.46 | 98.0 | 100 |
| Thymosin α1 | Tissue-repair | 6 n=6 | 99.50 | 99.40 | +0.10 | 97.5 | 100 |
| CJC-1295 (no DAC) | Growth-hormone | 5 n=5 | 99.36 | 99.09 | +0.27 | 98.0 | 100 |
| MGF | Growth-hormone | 3 n=3 | 99.39 | 99.29 | +0.10 | 97.5 | 100 |
| IGF-1 LR3 | Growth-hormone | 3 n=3 | 98.26 | 98.28 | -0.02 | 95.0 | 100 |
| PT-141 (Bremelanotide) | Melanocortin-receptor | 2 n=2 | n<3 | 99.38 | — | 98.5 | 50 |
| Ipamorelin | Growth-hormone | 2 n=2 | n<3 | 99.47 | — | 99.0 | 0 |
| L-Glutathione (reduced) | Short | 1 n=1 | n<3 | 99.33 | — | 98.5 | 100 |
| Liraglutide | Incretin | 1 n=1 | n<3 | 99.00 | — | 97.5 | 100 |
Which of these lines SGN actually stocks
Coverage here reflects what has been submitted to the index, not what is on the catalogue. Sangon Biotech (Shanghai) Co., Ltd. lists considerably more than the 21 compounds above. Of those 21, 15 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.